The “Microbial Metabolites and Chronic Pain” research axis explores the interactions between metabolites derived from the intestinal microbiota and the nervous system in the context of chronic pain. We are studying the role of the intestinal microbiota and its metabolites in the mechanisms of pain chronicization, in particular the involvement of the AhR/IL-22 pathway. We are also interested in the impact of microbial and/or tissue metabolites on the disturbances in “well-being” associated with chronic pain. Finally, we characterize new probiotics with anti-hyperalgesic potential, by evaluating their neuromodulatory power.
Journal articles
2024






2023




2022




2021
2020




2019




2018




2017




2016




2015




2014


2013
2012
2011
2010
2009


2008


2007
2006
1998
1995
1988


Conference papers
2020
2019
2017
Special issue
2024
Patents
2014
Poster communications
2023
2021
2020


2019
2017




2015
2006
Proceedings
2024